What is it about?
The paper presents a review of the current evidence of the efficacy and safety of belimumab in the treatment of patients with lupus erythematosus and also describes what are the ongoing clinical trials with this drug and other biologic drugs in these patients
Featured Image
Why is it important?
The paper tries to define what is the current place of belimumab in the treatment of patients with lupus
Perspectives
It is one of several reviews I published with my collaborators on the topic of recent progress in the treatment of systemic lupus erythematosus. Further papers will follow soon
Vladimir Tesar
Read the Original
This page is a summary of: Belimumab in the management of systemic lupus erythematosus – an update, Expert Opinion on Biological Therapy, May 2017, Taylor & Francis,
DOI: 10.1080/14712598.2017.1324846.
You can read the full text:
Contributors
The following have contributed to this page
